SEC Form 5 · accession 0001209191-16-098120
Kite Pharma, Inc. · KITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua A Kazam
Director
Period of report
Dec 31, 2015
Accepted (ET)
Feb 12, 2016 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510580
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 31, 2015 | G | 110,000 | $0.00 | D | 327,500 | D | |
| Common Stock | Nov 12, 2015 | G | 12,500 | $0.00 | D | 315,000 | D | |
| Common Stock | Nov 20, 2015 | G | 100,000 | $0.00 | D | 215,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The gifts described on Table 1 represent gifts by the Reporting Person for estate planning purposes to an irrevocable blind grantor trust, which is managed by an independent trustee, and to a charitable foundation. The Reporting Person holds no voting or dispositive power over the securities held by the trust.